GSK CEO addresses declining trust in vaccines following Trump re-election

GSK CEO addresses declining trust in vaccines following Trump re-election

Source: 
Clinical Trials Arena
snippet: 

GSK CEO Emma Walmsley said the sector would need to wait to see who is appointed in key roles in the Trump administration to gauge impact.